{"id":"W3182001862","doi":"10.1016/j.nbt.2021.07.001","title":"Opinion: Independent third-party entities as a model for validation of commercial antibodies","year":2021,"lang":"en","type":"article","venue":"New Biotechnology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of Toronto; McGill University; Structural Genomics Consortium","funders":"Ontario Genomics Institute; National Institute of General Medical Sciences; National Institute on Aging; Kungliga Tekniska Högskolan; Genentech; Innovative Medicines Initiative; Canada Foundation for Innovation; European Federation of Pharmaceutical Industries and Associations; ALS Association; Wellcome Trust; Janssen Pharmaceuticals; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Bayer; ALS Society of Canada; Takeda Canada; Royal Society of Canada; McGill University; Boehringer Ingelheim; Pfizer; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Foundation for the National Institutes of Health","keywords":"Incentive; Public domain; Computer science; Profit (economics); Domain (mathematical analysis); Antibody; Public opinion; Business; Data science; Political science; Economics; Medicine; Immunology; Microeconomics; Mathematics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001133708,0.0001213871,0.0003487879,0.0001623032,0.00008170625,0.00001038537,0.0001275086,0.0003503167,0.0001544999],"category_scores_gemma":[0.0001850587,0.0001056151,0.0001397127,0.000169905,0.0002005686,0.00004649354,0.0001661729,0.0002517602,0.00002830505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002766259,"about_ca_system_score_gemma":0.0004340338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001889878,"about_ca_topic_score_gemma":0.00006721647,"domain_scores_codex":[0.9989415,0.00002156949,0.000271598,0.000248649,0.0002584654,0.0002582006],"domain_scores_gemma":[0.9993158,0.00006841906,0.00007391122,0.000265579,0.0002021074,0.00007416815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001548051,0.0005642364,0.01075151,0.0008522712,0.0004252191,0.00005775984,0.0009001823,0.00006378739,0.653128,0.2587085,0.03871899,0.03428146],"study_design_scores_gemma":[0.001359273,0.0004310492,0.001259761,0.00008899752,0.00004258814,0.0001475655,0.000234474,0.002510356,0.9408267,0.01598132,0.0369908,0.0001271266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9348301,0.001811589,0.0112325,0.04810726,0.0003722435,0.0004811288,0.00009418689,0.0001174204,0.002953539],"genre_scores_gemma":[0.9761507,0.001992678,0.007906614,0.0005644581,0.0002492022,0.00002095434,0.0002235714,0.00001910336,0.01287275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2876987,"threshold_uncertainty_score":0.4306859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06077089442729143,"score_gpt":0.3609028639170184,"score_spread":0.300131969489727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}